Over the next 5 years, patent cliffs, turbulent geopolitical and legislative changes will continue to impact drug prices, availability and revenue.   Now more than ever, pharma and their supporting partners must keep costs down to capture savings to reinvest for the future.

To deliver performance improvements, companies are cutting costs in traditional ways while experimenting with AI in new ways. But progress is slow, and results are limited.  However, organizations that combine operating model changes with AI are delivering more meaningful and sustainable results. Are you getting the results desired to be prepared for the future? 

Join our global life sciences panellists for an interactive discussion to learn: 

- Strategies of world-class companies to achieve cost savings and operational excellence
- Insights into targeted operations and service delivery opportunities and obstacles to avoid
- Conditions required to maximum, sustainable value with AI
 
Discover how combining AI with strategic operating model changes can deliver meaningful and sustainable impact in your organization faster.